These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11778911

  • 1. Is there a role for antenatal TRH therapy for the prevention of neonatal lung disease?
    Gross I, Moya FR.
    Semin Perinatol; 2001 Dec; 25(6):406-16. PubMed ID: 11778911
    [Abstract] [Full Text] [Related]

  • 2. Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. ACTOBAT Study Group.
    Crowther CA, Hiller JE, Haslam RR, Robinson JS.
    Pediatrics; 1997 Mar; 99(3):311-7. PubMed ID: 9041281
    [Abstract] [Full Text] [Related]

  • 3. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group.
    Ballard RA, Ballard PL, Creasy RK, Padbury J, Polk DH, Bracken M, Moya FR, Gross I.
    Lancet; 1992 Feb 29; 339(8792):510-5. PubMed ID: 1346877
    [Abstract] [Full Text] [Related]

  • 4. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
    Ballard RA, Ballard PL, Cnaan A, Pinto-Martin J, Davis DJ, Padbury JF, Phibbs RH, Parer JT, Hart MC, Mannino FL, Sawai SK.
    N Engl J Med; 1998 Feb 19; 338(8):493-8. PubMed ID: 9468465
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R, Ozek E.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD000141. PubMed ID: 19160177
    [Abstract] [Full Text] [Related]

  • 7. Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences.
    Moya FR, Gross I.
    Semin Perinatol; 1993 Aug 21; 17(4):267-74. PubMed ID: 8140441
    [Abstract] [Full Text] [Related]

  • 8. Two trials of antenatal thyrotrophin-releasing hormone for fetal maturation: stopping before the due date. Antenatal TRH Trial and the Thyroneth Trial Groups.
    Alfirevic Z, Boer K, Borcklehurst P, Buimer M, Elbourne D, Kok J, Tansey S.
    Br J Obstet Gynaecol; 1999 Sep 21; 106(9):898-906. PubMed ID: 10492099
    [Abstract] [Full Text] [Related]

  • 9. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.
    Crowther CA, Alfirevic Z, Haslam RR.
    Cochrane Database Syst Rev; 2004 Sep 21; (2):CD000019. PubMed ID: 15106139
    [Abstract] [Full Text] [Related]

  • 10. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N, Soll R.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD007836. PubMed ID: 19370695
    [Abstract] [Full Text] [Related]

  • 11. Prevention of respiratory distress syndrome: synergistic therapies.
    Gross I.
    Mead Johnson Symp Perinat Dev Med; 1988 Apr 15; (33):37-41. PubMed ID: 2485442
    [Abstract] [Full Text] [Related]

  • 12. Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Collaborative Santiago Surfactant Group.
    Am J Obstet Gynecol; 1998 Jan 15; 178(1 Pt 1):33-9. PubMed ID: 9465799
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF, Morley CJ.
    Cochrane Database Syst Rev; 2001 Jan 15; (2):CD000510. PubMed ID: 11405966
    [Abstract] [Full Text] [Related]

  • 14. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation.
    Silver RK, Vyskocil C, Solomon SL, Ragin A, Neerhof MG, Farrell EE.
    Obstet Gynecol; 1996 May 15; 87(5 Pt 1):683-91. PubMed ID: 8677067
    [Abstract] [Full Text] [Related]

  • 15. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF, Hoekstra RE, Fangman JJ, Corbet AJ, Adams JM, James LS, Schulze K, Oh W, Roberts JD, Dorst JP.
    Pediatrics; 1990 Jun 15; 85(6):1092-102. PubMed ID: 2187176
    [Abstract] [Full Text] [Related]

  • 16. Prenatal hormone treatment with thyrotropin releasing hormone and with thyrotropin releasing hormone plus dexamethasone delays antioxidant enzyme maturation but does not inhibit a protective antioxidant enzyme response to hyperoxia in newborn rat lung.
    Rodriguez MP, Sosenko IR, Antigua MC, Frank L.
    Pediatr Res; 1991 Dec 15; 30(6):522-7. PubMed ID: 1805147
    [Abstract] [Full Text] [Related]

  • 17. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC, Soll RF.
    Cochrane Database Syst Rev; 2000 Dec 15; (2):CD001456. PubMed ID: 10796266
    [Abstract] [Full Text] [Related]

  • 18. Prenatal thyrotropin-releasing hormone for preterm birth.
    Crowther CA, Alfirevic Z, Haslam RR.
    Cochrane Database Syst Rev; 2000 Dec 15; (2):CD000019. PubMed ID: 10796087
    [Abstract] [Full Text] [Related]

  • 19. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.
    Farrell EE, Silver RK, Kimberlin LV, Wolf ES, Dusik JM.
    Am J Obstet Gynecol; 1989 Sep 15; 161(3):628-33. PubMed ID: 2675599
    [Abstract] [Full Text] [Related]

  • 20. Structural and transcriptomic response to antenatal corticosteroids in an Erk3-null mouse model of respiratory distress.
    Pew BK, Harris RA, Sbrana E, Guaman MC, Shope C, Chen R, Meloche S, Aagaard K.
    Am J Obstet Gynecol; 2016 Sep 15; 215(3):384.e1-384.e89. PubMed ID: 27143398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.